(1) In the case of products which constitute insurance-based investment products within the meaning of Article 2 (1) no. 17 of Directive (EU) 2016/97, appropriate information on the distribution of insurance-based investment products, and on all costs and charges, is made available to the policyholder in good time prior to the conclusion of the contract. This information includes the following as a minimum:
1. if advice is provided, information as to whether the policyholder is offered a regular assessment, in accordance with section 7c, of the suitability of the insurance-based investment product that is being recommended to that policyholder;
2. appropriate guidelines and warnings on the risks associated with insurance-based investment products, or with specific investment strategies that have been proposed;
3. information on the distribution of the insurance-based investment product, including the cost of advice and the cost of the insurance-based investment product that is being recommended to the policyholder;
4. how the policyholder can effect payments, including third-party payments.
(2) Information on all costs and charges, including costs and charges related to the distribution of the insurance-based investment product, which are not caused by the underlying market risk, is provided in aggregate form; the total costs and the cumulative effect on the investment return must be understandable; furthermore, a list of the costs and charges is made available to the policyholder at his or her request. This information is made available to the policyholder on a regular basis, but at least annually, during the life of the investment.